Navigation Links
ARUP Laboratories CEO and Co-Founder Announces Retirement
Date:4/16/2008

SALT LAKE CITY, April 16 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today that company co-founder Carl R. Kjeldsberg, MD, will retire as chief executive officer (CEO) at the end of June 2009. Kjeldsberg has held the position since 1993 and will continue after his retirement to serve as chairman of the Board.

Effective, July 1, 2009, Edward R. Ashwood, MD, will assume the position of CEO of ARUP Laboratories. Ashwood, director of laboratories and chief medical officer, has been with ARUP for 22 years and has been a member of its executive management team for the last 12 years. He is a tenured professor of Pathology at the University of Utah School of Medicine and is board certified in clinical and chemical pathology.

"During my years at ARUP, the company has gone through an incredible amount of change. I have a great sense of pride in what our leadership team has accomplished under my tenure as CEO and I look forward to continuing to contribute to the future success as chairman of the Board," said Kjeldsberg.

"ARUP has positioned itself for the future by developing leaders who continue to drive the ongoing growth and success of our laboratory. Dr. Ashwood brings many years of experience and successful leadership to his new role at ARUP," continued Kjeldsberg.

"I am honored to have the opportunity to lead the company and further build on its past successes. Our priorities as a company will continue to center around our core strategic initiatives of supporting patients as well as our clients' existing test menus by offering highly complex tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services," said Ashwood. "I am very excited about the future and the opportunities that lie ahead for ARUP."

About ARUP Laboratories

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and an enterprise of the University of Utah and its Department of Pathology. With 2,100 employees, ARUP offers more than 2,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country. ARUP's clients include more than half of the nation's university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(R). For more information about ARUP Laboratories, please visit http://www.aruplab.com.


'/>"/>
SOURCE ARUP Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories
2. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
3. Stonegate Report About Unigene Laboratories Inc.
4. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
5. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
6. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
7. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
8. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
9. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
10. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ATLANTA , Feb. 11, 2016  Spectra BioPharma ... Organization (CSO) that provides biopharma companies the experience, ... implement and deploy outsourced sales teams. Created in ... team addresses both the strategic and tactical needs ... innovative sales solutions through both personal and non-personal ...
(Date:2/11/2016)... , Feb. 11, 2016   BioInformant ... report, "Stem Cell Research Products, Opportunities, Tools, and Technologies ... ... in the stem cell industry, BioInformant has more than ... the stem cell market, by stem cell type. This ...
(Date:2/10/2016)... , February 10, 2016 Early-career researchers ... , Peru , Uganda and ... life-enhancing work in health and nutrition   Indonesia ... Uganda and Yemen are being ... and epidemiology. They are also celebrated for mentoring young women scientists who ...
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
Breaking Biology Technology:
(Date:2/2/2016)...   Parabon NanoLabs (Parabon) announced today ... Office and the Defense Forensics and Biometrics Agency ... company,s Snapshot Kinship Inference software for ... defense-related DNA forensics.  Although Snapshot is best known ... ancestry from DNA evidence), it also has the ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
(Date:2/1/2016)... MELBOURNE, Fla. , Feb. 1, 2016  Wocket® smart wallet ( ... actor and television personality, Joey Fatone . Las ... and greet fans. --> Las Vegas , ... --> The new video ad was filmed at the ... Joey appeared at the Wocket booth to meet and greet fans. ...
Breaking Biology News(10 mins):